GaryBradleySherrillMD

PubMed

• 11 citations
  Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer
  John H. Strickler, Christel Rushing, Hope E. Uronis, Michael A. Morse, Donna Niedzwiecki, Gerard C. Blobe, Ashley Moyer, Emily Bolch, Renee Webb, Sherri Haley, Ace J. ...> ;The Oncologist. 2021 Jun 1
• 17 citations
  Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay.
  Katherine Clifton, Thereasa A. Rich, Christine Megerdichian Parseghian, Victoria M. Raymond, Arvind Dasari, Allan Andresson Lima Pereira, Jason Willis, Jonathan M. Lor...> ;JCO Precision Oncology. 2019 Oct 3
• 19 citations
  Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer
  Hanna K. Sanoff, Richard M. Goldberg, Anastasia Ivanova, Seamus O'Reilly, Samer S. Kasbari, Richard D. Kim, Ray McDermott, Dominic T. Moore, William C. Zamboni, Willia...> ;Cancer. 2018 Aug 1
• 34 citations
  A Community-Based Multicenter Trial of Pharmacokinetically Guided 5-Fluorouracil Dosing for Personalized Colorectal Cancer Therapy
  Jai N. Patel, Bert H. O'Neil, Allison M. Deal, Joseph G. Ibrahim, Gary Bradley Sherrill, Oludamilola Olajide, Prashanti Atluri, John J. Inzerillo, Christopher H. Chay,...> ;The Oncologist. 2014 Sep 1
• 36 citations
  Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer.
  Beth O. Van Emburgh, Jennifer J. Hu, Edward A. Levine, Libyadda J. Mosley, Nancy D. Perrier, Rita I. Freimanis, Glenn O. Allen, Peter Rubin, Gary Bradley Sherrill, Cin...> ;Oncology Reports. 2008 May 1
• 20 citations
  Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer
  Beth O. Van Emburgh, Jennifer J. Hu, Edward A. Levine, Libyadda J. Mosley, L. Douglas Case, Hui-Yi Lin, Sommer N. Knight, Nancy D. Perrier, Peter Rubin, Gary Bradley S...> ;Molecular Carcinogenesis. 2008 Feb 1
• Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.
  Fisher, D. C., Sherrill, G. B., Hussein, A., Rubin, P., Vredenburgh, J. J., Elkordy, M., Ross, M., Petros, W., Peters, W. P.> ;Bone Marrow Transplant. 1996 Jul
• Structural and functional characteristics of activated human factor IX after chemical modification of gamma-carboxyglutamic acid residues.
  Straight, D. L., Sherrill, G. B., Noyes, C. M., Trapp, H. G., Wright, S. F., Roberts, H. R., Hiskey, R. G., Griffith, M. J.> ;J Biol Chem. 1985 Mar 10
• Carboxylate polyanions accelerate inhibition of thrombin by heparin cofactor II.
  Church, F. C., Treanor, R. E., Sherrill, G. B., Whinna, H. C.> ;Biochem Biophys Res Commun. 1987 Oct 14
• Use of p-aminobenzamidine to monitor activation of trypsin-like serine proteases.
  Monroe, D. M., Sherrill, G. B., Roberts, H. R.> ;Anal Biochem. 1988 Aug 1
• Calcium enhances factor Xa activity independent of gamma-carboxyglutamic acid residues.
  Sherrill, G. B., Meade, J. B., Kalayanamit, T., Monroe, D. M., Church, F. C.> ;Thromb Res. 1988 Oct 1
• Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thro...
  Church, F. C., Pratt, C. W., Noyes, C. M., Kalayanamit, T., Sherrill, G. B., Tobin, R. B., Meade, J. B.> ;J Biol Chem. 1989 Nov 5
• Join now to see all